Journal Mobile Options
Table of Contents
Vol. 56, No. 4, 2007
Issue release date: April 2008
Neuropsychobiology 2007;56:172–179
(DOI:10.1159/000119735)

Circadian Variation of Core Body Temperature in Parkinson Disease Patients with Depression: A Potential Biological Marker for Depression in Parkinson Disease

Suzuki K. · Miyamoto T. · Miyamoto M. · Kaji Y. · Takekawa H. · Hirata K.
Department of Neurology, Dokkyo Medical University, Tochigi, Japan

Individual Users: Register with Karger Login Information

Please create your User ID & Password





Contact Information











I have read the Karger Terms and Conditions and agree.

To view the fulltext, please log in

To view the pdf, please log in

Abstract

Background: The biological rhythm in comorbidity of depression and Parkinson disease (PD) is still unclear. For early diagnosis or clarification of the pathologic condition of comorbidity of depression and PD, the present study investigated the presence of circadian rhythm abnormalities in patients with depression. Methods: We measured the rectal temperature (RT) in 30 PD patients with or without depression during 48 consecutive hours using the maximum entropy method (MEM) and least-squares method (COSINOR). The presence of major or minor depression was evaluated by the Mini International Neuropsychiatric Interview based on the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders, and the Hamilton Depression Scale. Results: The RT rhythms of patients without depression predominately showed a circadian rhythm. However, 2 of 6 patients with depression showed an infradian rhythm using MEM. COSINOR revealed that PD patients with depression showed lower amplitudes of core body temperature (p = 0.012) and higher minimum RT (p = 0.031) relative to those of patients without depression. Conclusion: PD patients with depression show an altered RT circadian rhythm. The results suggest that the characteristics of core body temperature could be potentially used as a biological marker for depression in PD.



Copyright / Drug Dosage

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in goverment regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

References

  1. Adler CH, Thorphy MJ: Sleep issues in Parkinson’s disease. Neurology 2005;64(suppl 3):S12–S20.
  2. Ben V, Bruguerolle B: Effects of bilateral striatal 6-OHDA lesions on circadian rhythms in the rat: a radiotelemetric study. Life Sci 2000;67:1549–1558.
  3. Pierangeli G, Provini F, Maltoni P, Barletta G, Contin M, Lugaresi E, Montagna P, Cortelli P: Nocturnal body core temperature falls in Parkinson’s disease but not in multiple-system atrophy. Mov Disord 2001;16:226–232.
  4. Hartmann A, Veldhuis JD, Deuschle M, Standhardt H, Heuser I: Twenty-four hour cortisol release profiles in patients with Alzheimer’s and Parkinson’s disease compared to normal controls: ultradian secretory pulsatility and diurnal variation. Neurobiol Aging 1997;18:285–289.
  5. Bordet R, Devos D, Brique S, Touitou Y, Guieu JD, Libersa C, Destee A: Study of circadian melatonin secretion pattern at different stages of Parkinson’s disease. Clin Neuropharmacol 2003;26:65–72.
  6. Fertl E, Auff E, Doppelbauer A, Waldhauser F: Circadian secretion pattern of melatonin in de novo parkinsonian patients: evidence for phase-shifting properties of L-dopa. J Neural Transm Park Dis Dement Sect 1993;5:227–234.
  7. Cummings JL: Depression and Parkinson’s disease. Am J Psychiatry 1992;149:443–454.
  8. Chaudhuri KR, Martinez-Martin P: Clinical assessment of nocturnal disability in Parkinson’s disease. Neurology 2004;63(suppl 3):S17–S20.
  9. Tandberg E, Larsen JP, Karlsen K: A community-based study of sleep disorders in patients with Parkinson’s disease. Mov Disord 1998;13:895–899.
  10. Mayeux R, Stern Y, Williams JB, Cote L, Frantz A, Dyrenfurth I: Clinical and biochemical features of depression in Parkinson’s disease. Am J Psychiatry 1986;143:756–759.
  11. Kostic VS, Djuricic BM, Covickovic-Sternic N, Bumbasirevic L, Nikolic M, Mrsulja BB: Depression and Parkinson’s disease: possible role of serotonergic mechanisms. J Neurol 1987;234:94–96.
  12. Mayberg HS, Starkstein SE, Sadzot B, Preziosi T, Andrezejewski PL, Dannals RF, Wagner HN Jr, Robinson RG: Selective hypometabolism in the inferior frontal lobe in depressed patients with Parkinson’s disease. Ann Neurol 1990;28:57–64.
  13. Daimon K, Yamada N, Tsujimoto T, Takahashi S: Circadian rhythm abnormalities of deep body temperature in depressive disorders. J Affect Disord 1992;26:191–198.
  14. Wehr TA, Wirz-Justice A: Circadian rhythm mechanisms in affective illness and in antidepressant drug action. Pharmacopsychiatria 1982;15:31–39.
  15. Bleecker ML, Bolla-Wilson K, Kawas C, Agnew J: Age-specific norms for the Mini-Mental State Exam. Neurology 1988;38:1565–1568.
  16. Hughes AJ, Daniel SE, Kilford L, Lees AJ: Accuracy of clinical diagnosis of idiopathic Parkinson’s disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 1992;55:181–184.
  17. Hoehn MM, Yahr MD: Parkinsonism: onset, progression and mortality. Neurology 1967;17:427–442.
  18. Fahn S, Elton RL, Members of the UPDRS Development Committee: Unified Parkinson’s disease rating scale; in Fahn S, Marsden CD, Calne DB, Goldstein M (eds): Recent Development in Parkinson’s Disease. Florham Park, MacMillan Healthcare Information, 1987, pp 153–164.
  19. Johns MW: A new method for measuring daytime sleepiness: the Epworth sleepiness scale. Sleep 1991;14:540–545.
  20. Buysse DJ, Reynolds CF III, Monk TH, Berman SR, Kupfer DJ: The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res 1989;28:193–213.
  21. Sheehan DV, Lecrubier Y, Sheehan KH, Amorim P, Janavs J, Weiller E, Hergueta T, Baker R, Dunber GC: The Mini-International Neuropsychiatric Interview (MINI): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry 1998;59:22–23.
  22. Hamilton M: A rating scale for depression. J Neurol Neurosurg Psychiatry 1960;23:56–62.
  23. Kaji Y, Hirata K, Ebata A: Characteristics of post-stroke depression in Japanese patients. Neuropsychobiology 2006;53:148–152.
  24. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, ed 4. Washington, American Psychiatric Association Press, 1994.
  25. Roose SP, Sackeim HA, Krishnan KR, Pollock BG, Alexopoulos G, Lavretsky H, Katz IR, Hakkarainen H; Old-Old Depression Study Group: Antidepressant pharmacotherapy in the treatment of depression in the very old: a randomized, placebo-controlled trial. Am J Psychiatry 2004;161:2050–2059.
  26. Akaike H: Fitting autoregressive models for prediction. Ann Inst Statist Math 1969;21:243–247.

    External Resources

  27. Akaike H: Power spectrum estimation through autoregressive model fitting. Ann Inst Statist Math 1969;21:407–419.

    External Resources

  28. Chen WY, Stegen GR: Experiments with maximum entropy power spectra of sinusoids. J Geophys Res 1974;79:3019–3022.

    External Resources

  29. Otsuka K, Watanabe H: Experimental and clinical chronocardiology. Chronobiologia 1990;17:135–163.
  30. Radoski HR, Fougere PF, Zawalick EJ: A comparison of power spectral estimates and applications of the maximum entropy method. J Geophys Res 1975;80:619–625.

    External Resources

  31. Tsujimoto T, Yamada N, Shimoda K, Hanada K, Takahashi S: Circadian rhythms in depression. 1. Monitoring of the circadian body temperature rhythm. J Affect Disord 1990;18:193–197.
  32. Tsujimoto T, Yamada N, Shimoda K, Hanada K, Takahashi S: Circadian rhythms in depression. 2. Circadian rhythms in inpatients with various mental disorders. J Affect Disord 1990;18:199–210.
  33. Halberg F: Glossary and abbreviations; in Halberg F, Watanabe H (eds): Chronobiology and Chronomedicine. Tokyo, Medical Reviews, 1992, pp 5–8.
  34. Lieberman A: Depression in Parkinson’s disease. Acta Neurol Scand 2006;113:1–8.
  35. Brown RG, MacCarthy B: Psychiatric morbidity in patients with Parkinson’s disease. Psychol Med 1990;20:77–87.
  36. Ehmann TS, Beninger RJ, Gawel MJ, Riopelle RJ: Depressive symptoms in Parkinson’s disease: a comparison with disabled control subjects. J Geriatr Psychiatry Neurol 1990;3:3–9.
  37. Campbell SS, Gillin JC, Kripke DF, Erikson P, Clopton P: Gender differences in the circadian temperature rhythms of healthy elderly subjects: relationships to sleep quality. Sleep 1989;12:529–536.
  38. Moe KE, Prinz PN, Vitiello MV, Marks AL, Larsen LH: Healthy elderly women and men have different entrained circadian temperature rhythms. J Am Geriatr Soc 1991;39:383–387.
  39. Nakazawa Y, Nonaka K, Nishida N, Hayashida N, Miyahara Y, Kotorii T, Matsuoka K: Comparison of body temperature rhythms between healthy elderly and healthy young adults. Jpn J Psychiatry Neurol 1991;45:37–43.
  40. Duffy JF, Dijk DJ, Klerman EB, Czeisler CA: Later endogenous circadian temperature nadir relative to an earlier wake time in older people. Am J Physiol 1998;275:1478–1487.
  41. Olson RW: Drug interactions at the GABA receptor-ionophore complex. Annu Rev Pharmacol Toxicol 1982;22:245–277.
  42. Ralph MR, Menaker M: Effects of diazepam on circadian phase advances and delays. Brain Res 1986;372:405–408.
  43. Subramanian P, Subbaraj R: Diazepam modulates the period of locomotor rhythm in mice (Mus booduga) and attenuates light-induced phase advances. Pharmacol Biochem Behav 1996;54:393–398.
  44. Subramanian P, Subbaraj R: Diazepam phase shifts the circadian clock of the field mouse Mus booduga. J Biosci 1993;18:103–110.
  45. Ralph MR, Menaker M: GABA regulation of circadian responses to light. 1. Involvement of GABAA-benzodiazepine and GABAB receptors. J Neurosci 1989;9:2858–2865.
  46. Childs G, Redfern PH: A circadian rhythm in passive avoidance behavior: the effect of phase shift and the benzodiazepines. Neuropharmacology 1981;20:1365–1366.
  47. Djeridane Y, Lemmer B, Touitou Y: Diazepam affects both level and amplitude of rat locomotor activity rhythm but has no effect on core body temperature. Chronobiol Int 2005;22:975–985.
  48. Jellinger KA: Pathology of Parkinson’s disease: changes other than the nigrostriatal pathway. Mol Chem Neuropathol 1991;14:153–197.
  49. Benloucif S, Wolfe LF, Zee PC: Circadian neurobiology; in Chokroverty S, Hening WA, Walters AS (eds): Sleep and Movement Disorders. Philadelphia, Elsevier Science, 2003, pp 69–81.
  50. Aston-Jones G, Chen S, Zhu Y, Oshinsky ML: A neural circuit for circadian regulation of arousal. Nat Neurosci 2001;4:732–738.
  51. Shneerson JM: Circadian rhythm disorders; in Shneerson JM (ed): Sleep Medicine: A Guide to Sleep and Its Disorders, ed 2. Massachusetts, Blackwell Publishing, 2005, pp 107–124.
  52. Wolters EC, Braak H: Parkinson’s disease: premotor clinico-pathological correlations. J Neural Transm Suppl 2006;70:309–319.

    External Resources

  53. Taylor A, Saint-Cyr JA, Lang AE, Kenny FT: Parkinson’s disease and depression: a critical re-evaluation. Brain 1986;109:279–292.


Pay-per-View Options
Direct payment This item at the regular price: USD 38.00
Payment from account With a Karger Pay-per-View account (down payment USD 150) you profit from a special rate for this and other single items.
This item at the discounted price: USD 26.50